Research Article

A Novel Severity Score Index for Febrile Neutropenic Patients with Colorectal Diseases

Table 1

MASCC risk index factors and weights [3].

CharacteristicWeight

Burden of febrile neutropenia with no or mild symptomsI5
No hypotension (systolic )5
No chronic obstructive pulmonary diseaseII4
Solid tumor or hematological malignancy with no previous fungal infectionIII4
No dehydration requiring parenteral fluids3
Burden of febrile neutropenia with moderate symptomsIV3
Outpatient status3
years2

MASCC (Multinational Association of Supportive Care in Cancer). IBurden of febrile neutropenia refers to general clinical status as influenced by the febrile neutropenic episode. It is evaluated in accordance with the following scale: no symptoms (5), mild symptoms (5), moderate symptoms (3), severe symptoms (0), and moribund (0). IIChronic obstructive pulmonary disease means active chronic bronchitis, emphysema, decrease in FEVs, need for oxygen therapy, and/or steroids and/or bronchodilators. IIIPrevious fungal infection means demonstrated fungal infection or empirically treated suspected fungal infection. IVThe points attributed to the variable “burden of febrile neutropenia” are not cumulative. Thus, the maximum theoretical score is therefore 26. A score of ≥21 is considered low risk and a score of <21 as high risk (positive predictive value of 91%, specificity of 68%, and sensitivity of 71%).